The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer

Using transcriptome meta-analysis, we recently identified the autotaxin (ATX)-lysophosphatidic acid (LPA) pathway as a regulator of hepatocellular carcinoma (HCC) risk in human cirrhosis patients. Pharmacological targeting of this pathway reduced fibrosis progression and HCC development in animals,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Cell Oncol
Autors principals: Erstad, Derek J., Tager, Andrew M., Hoshida, Yujin, Fuchs, Bryan C.
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2017
Matèries:
Author's View
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5462520/
https://ncbi.nlm.nih.gov/pubmed/28616586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2017.1311827
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars